“Almac’s enhanced RNA-Seq reporting solution claraT – Simplifying complex biologies within the Hallmarks of Cancer.”
RNA Sequencing (RNA-seq) is an increasingly popular technology for biomarker discovery in cancer research. High-throughput RNA-seq produces large quantities of complex data that require computational bioinformatics
pipelines to enable interpretation.
Almac Diagnostic Services has developed claraT – A unique software-driven solution, classifying biologically relevant gene expression signatures into a comprehensive, easy-to-interpret report.
The claraT report outputs include the entire study cohort and individual sample reports from Almac internally developed bioinformatics pipelines. claraT reports on relevant public and proprietary gene expression signatures as well as single gene targets within the Hallmarks of Cancer using Almac’s optimized RNA exome panel.
WHAT YOU WILL LEARN:
- The structure and layout of the claraT report
- A detailed walk through of both the cohort and sample summaries
- How the claraT report can support biomarker discovery
- Future plans for developing the claraT report
Dr. Steven Walker, Head of Internal Product Development, Almac Diagnostic Services.